Tg Therapeutics reported $-35818000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US USD 2.54B 364M
Ardelyx ARDX:US USD -22893000 4.04M
Arrowhead Research ARWR:US USD -82157000 10.11M
Biogen BIIB:US USD 821M 53.8M
Curis CRIS:US USD -13294000 2.65M
Infinity Pharmaceuticals INFI:US USD -10717000 1.27M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Johnson & Johnson JNJ:US USD 7.42B 655M
Karyopharm Therapeutics KPTI:US USD -36279000 12.66M
Novartis NOVN:VX USD 4.06B 72M
Novavax NVAX:US USD -166141000 342.93M
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Roche Holding ROG:VX 12.11B 2.43B
Spectrum Pharmaceuticals SPPI:US USD -21913000 7.12M
Tg Therapeutics TGTX:US USD -35818000 4.69M
Verastem VSTM:US USD -18090000 3.86M